The doctor may need to consider prior dose, side effects, current appetite, blood sugar status, constipation or nausea history, hydration, weight trajectory, lab markers, cost, access, and maintenance goals
Postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, an obesity drug sold by Eli Lilly (NYSE: LLY) under the brand names Mounjaro and Zepbound
Since branded semaglutide and tirzepatide are now fully available, prescribers are expected to document that the compounded version serves a specific individualized medical need that the branded version cannot
doi: 10.3389/fcdhc.2026.1772391 Received 20 December 2025 Revised 15 March 2026 Accepted 16 March 2026 Published 10 April 2026 Volume 7 - 2026 Edited by Arrigo Francesco Giuseppe Cicero, University of Bologna, Italy Reviewed by Alessando Mattina, IRRCS ISMETT/UPMC Italy, Italy Updates Copyright 2026 Jdrasek, Lisowska and Czupryniak
Timing can play a significant role in how well your body utilizes supplements
In animal studies, tissue healing improvements have been observed within 12 weeks, with more significant results documented at 24 weeks depending on the injury model